In head and neck squamous cell carcinomas (HNSCCs), IDO1 inversely correlates with programmed cell death protein ligand 1, which constitutes an important prognostic biomarker for immune-checkpoint inhibition (11). This evidence concerns the gene IDO1 and head and neck squamous cell carcinoma.